¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"phase ratio"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
¼³¸í
optimal ratio
ÃÖÀûºñ
optimum ratio
ÃÖÀûºñ
ratio
ºñ
¾î¶² ¹°Áú ¶Ç´Â ½ÇüÀÇ ¾çÀ» ´Ù¸¥ °Í°ú ºñ±³ÇÑ Ç¥ÇöÀ¸·Î¼, º¸Åë ÇÑÂÊÀÇ ¾çÀ» ´Ù¸¥ÂÊÀÇ ¾çÀ¸·Î ³ª´« °ªÀ¸·Î Ç¥½ÃÇÑ´Ù.
sex ratio
¼ººñ
signal-to-noise ratio
½ÅÈ£-ÀâÀ½ºñ, ½ÅÈ£´ë ¼ÒÀ½ ºñÀ²
train of four ratio
»ç¿¬¼Ó ¹ÝÀÀºñ
unharmonic ratio
ºñÁ¶Èºñ
uptake ratio
¼·ÃëÀ²
ventilation perfusion ratio
ȯ±âÀ²
W/P ratio
È¥¼öºñ
¼®°íÀÇ ¿¬È¿¡ »ç¿ëµÇ´Â ¹°ÀÇ ¾ç°ú ¼®°í ºÐ¸»ÀÇ ¹«°Ô ºñ.
accelerated death phase
°¡¼Ó »ç¸ê±â
acceleration phase
ÃËÁø±â, °¡¼Ó±â
¹Ì»ý¹° ¹è¾ç ½Ã °©Àڱ⠼ºÀåÀÌ Áõ°¡ÇÏ´Â ½Ã±â.
acute phase protein
±Þ¼º±â ´Ü¹éÁú
°¨¿°À̳ª Á¶Á÷ ¼Õ»óÀÌ ÀÖÀ» ¶§ Á¤»óº¸´Ù 2-100¹è Á¤µµ Áõ°¡ÇÏ´Â Ç÷Àå ´Ü¹éÁúÀ» ÃÑĪÇÏ¿© APP¶ó°í ÇÏ¸ç ¼±Ãµ¼º ¸é¿ª¿¡ °ü¿©ÇÑ´Ù.
acute phase reaction
±Þ¼º±â ¹ÝÀÀ
acute phase serum
±Þ¼º º´±â Ç÷û
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½